• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SU Wenmei,WANG Yan,YE Haiyin,MAI Zongjiong,GUO Kangwen,YANG Zhixiong.Expression of Livin in lung cancer and its correlation with Fas/FasL[J].Journal Of Pharmaceutical Research,2016,35(10):610-613[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3729times   Download 3515次 QR Code for this article
Scan with your phone!
Livin与Fas/FasL在肺癌中表达的意义及其关系
苏文媚,王焱,叶海茵,麦宗炯,郭康文,杨志雄
Font:Larger+|Default|Smaller-
(广东医科大学附属医院肿瘤中心,广东 湛江 524001)
摘要:
目的 检测肺癌组织中Livin和Fas/FasL的表达水平,研究它们与临床病理特征的关系及其相互关系,为肺癌的早期诊断、治疗及靶向药物研发提供线索。方法 采用免疫组织化学来检测肺癌组织216例、癌旁肺组织90例、肺良性病变组织45例中Livin、Fas和FasL 基因的表达情况。结果 Livin在肺癌组织、癌旁肺组织、良性病变组织中阳性表达分别为:63.43%、14.44%、13.33%,差异有统计学意义(P<0.01);Fas在肺癌组织、癌旁肺组织、良性病变组织中阳性表达分别为:53.24%、83.33%、86.67%,其差异有统计学意义(P <0.01);Fas表达与病理学分级相关(P<0.05);FasL在肺癌中表达、淋巴结转移与病理学分级及TNM分期相关(P<0.05)。结论 研究结果提示Livin和Fas/FasL可能作为凋亡相关的基因参与了肺癌的发生发展。
关键词:  肺癌  Livin  Fas  FasL  免疫组织化学
DOI:10.13506/j.cnki.jpr.2016.10.014
基金项目:广东省科技项目(No.2014A020212459)
Expression of Livin in lung cancer and its correlation with Fas/FasL
SU Wenmei,WANG Yan,YE Haiyin,MAI Zongjiong,GUO Kangwen,YANG Zhixiong
(Cancer Center of Affiliated Hospital of Guangdong Medical University,Zhanjiang 524001,China)
Abstract:
Objective To study Livin protein expression in lung cancer and its relationship with the expression of Fas and FasL.Methods Immunohistochemical method was used to detect the expressions of Livin,Fas and FasL in 216 cases of lung cancer,90 cases of adjacent tumor tissues and 45 cases of benign pulmonary disease tissues.Results The positive rate (53.24%) of Fas in lung cancers was significantly lower than that in adjacent tumor tissues (83.33%) and benign tissues (86.67%).The difference was significant(P<0.01).The positive rate of Fas associated with pathological types is differentiation(P <0.05);The positive rate of FasL was related to clinical stage, lymph node metastasis and pathological classing(P <0.05).Conclusion Our findings suggested that Livin and Fas/FasL may be the apoptosis-related gene involved in the occurrence and development of lung cancer.
Key words:  Lung cancer  Livin  Fas  FasL  Immunihistochemistry
Today's Visits:465    Total Visits:2383161
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.